Micron Technology (NASDAQ:MU): Surveys conducted by Bernstein indicate that DRAM contract prices have increased a further 10 percent, maintaining a strong trend and a positive outlook on both DRAM’s and NAND’s structural recoveries. Bernstein keeps an Outperform rating.
Las Vegas Sands (NYSE:LVS): Following meetings in Macau, Sterne Agee find that Las Vegas Sands and other Macau companies are facing stricter smoking laws, as well as larger rebates by some casino operators, which could dent the momentum of Macau casino stocks. Despite the risks, the firm is more optimistic on Macau’s gross gaming revenue, and expects a 16 percent increase this year. The firm keeps a Buy rating on Sands shares.
Cardinal Health (NYSE:CAH): Argus considers valuation of Cardinal attractive, and believes the termination of its contract with Walgreen’s will be beneficial for its margins. The company’s Chinese operations, generics and specialty distribution businesses will perform well, and the firm retains its Buy rating.
Don’t Miss: Is Fracking Really Depleting Our Water Supplies?